EGFR Inhibitor as Second-Line Therapy in a Patient With...

EGFR Inhibitor as Second-Line Therapy in a Patient With Mutant RAS Metastatic Colorectal Cancer: Circulating Tumor DNA to Personalize Treatment

Gazzaniga, Paola, Raimondi, Cristina, Urbano, Federica, Cortesi, Enrico
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
JCO Precision Oncology
DOI:
10.1200/po.17.00277
Date:
April, 2018
File:
PDF, 900 KB
english, 2018
Conversion to is in progress
Conversion to is failed